GlassScriptPhysician profile
Aleah P Gibson
NPI 1780792903
$4,735.97
in general payments reported to CMS, 2019-2025
40 companies · $987 in 2025
The $987 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $823 · 2021: $68.64 · 2022: $508 · 2023: $840 · 2024: $1,079 · 2025: $987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,906.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $610.69 | 2022-2025 | |
| Novo Nordisk INC | $483.71 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $391.11 | 2019-2025 | |
| Amgen INC. | $337.14 | 2019-2023 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $249.51 | 2020-2025 | Jardiance, Zepbound, Mounjaro |
| Exact Sciences Corporation | $247.46 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $247.25 | 2022-2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $231.49 | 2019-2025 | Farxiga, Bevespi Aerosphere |
| Glaxosmithkline, LLC. | $231.03 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $205.97 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $154.99 | 2019-2024 | Vaxelis, Gardasil 9, M-M-R II |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.34 | 2019-2024 | Xifaxan, Trulance |
| Mdd US Operations, LLC | $99.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.58 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.97 | 2019-2025 | Trintellix |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleah Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.